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Abstract
Background: Neural induction of human pluripotent stem cells often yields heterogeneous cell populations that can
hamper quantitative and comparative analyses. There is a need for improved differentiation and enrichment procedures
that generate highly pure populations of neural stem cells (NSC), glia and neurons. One way to address this problem is to
identify cell-surface signatures that enable the isolation of these cell types from heterogeneous cell populations by
fluorescence activated cell sorting (FACS).
Methodology/Principal Findings: We performed an unbiased FACS- and image-based immunophenotyping analysis using
190 antibodies to cell surface markers on naı ¨ve human embryonic stem cells (hESC) and cell derivatives from neural
differentiation cultures. From this analysis we identified prospective cell surface signatures for the isolation of NSC, glia and
neurons. We isolated a population of NSC that was CD184
+/CD271
2/CD44
2/CD24
+ from neural induction cultures of hESC
and human induced pluripotent stem cells (hiPSC). Sorted NSC could be propagated for many passages and could
differentiate to mixed cultures of neurons and glia in vitro and in vivo. A population of neurons that was CD184
2/CD44
2/
CD15
LOW/CD24
+ and a population of glia that was CD184
+/CD44
+ were subsequently purified from cultures of
differentiating NSC. Purified neurons were viable, expressed mature and subtype-specific neuronal markers, and could
fire action potentials. Purified glia were mitotic and could mature to GFAP-expressing astrocytes in vitro and in vivo.
Conclusions/Significance: These findings illustrate the utility of immunophenotyping screens for the identification of cell
surface signatures of neural cells derived from human pluripotent stem cells. These signatures can be used for isolating
highly pure populations of viable NSC, glia and neurons by FACS. The methods described here will enable downstream
studies that require consistent and defined neural cell populations.
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Introduction
Human embryonic stem cells (hESC) and human induced
pluripotent stem cells (hiPSC) have the ability to differentiate to
somatic-like cells [1,2,3]. Thus, hESC and hiPSC differentiation
offers a unique opportunity for therapy development, drug
screening, disease modeling, and tissue replacement. However,
developing well-defined conditions to generate pure populations of
specific cell types is critical to achieve these goals.
There are several neural induction methods that enrich for NSC
or neurons using spontaneous differentiation, chemical induction
or mouse stromal feeder cells [4,5,6,7,8,9]. NSC can be manually
isolated and be propagated as monolayer cultures for many
passages [10,11]. In principle, these cells can differentiate to
neurons and glia, providing an endless supply of cells for in vitro
and in vivo assays. Unfortunately, the robustness of these methods
is hampered by batch-to-batch variability of isolated NSC.
Moreover, differentiation of NSC often results in variable and
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17540heterogeneous cultures of neurons, glia and undifferentiated cells,
which impedes many downstream applications requiring purified
or defined cell populations, such as in vitro assays, transplantation
and microarrays [12,13]. One possible solution to this problem is
to identify cell surface markers expressed on NSC, glia and
neurons to define and purify distinct cell types, similar to what has
been accomplished in studies of hematopoiesis.
Cell surface marker expression has been described for the
identification and isolation of many neural cell types by FACS
from embryonic and adult tissue from multiple species. The
glycoprotein CD133 is a known stem/progenitor cell marker in
many tissues and has been used to isolate NSC from human brain
[14,15,16,17]. The carbohydrate moiety CD15, also known as
stage-specific embryonic antigen-1 or LeX, has been used to
isolate NSC and radial glia from the subventricular zone (SVZ) in
mice [18,19]. CD184, a G protein-coupled receptor, was
successfully used in combination with CD15 to isolate NSC from
mouse embryonic forebrain and adult SVZ [20]. CD24 is a cell
adhesion molecule that has been used to isolate NSC from mouse
brain by FACS [21,22]. Maric et al. were successful in isolating
neuronally-restricted cells and NSC from embryonic rat telen-
cephalon based on surface expression of tetanus toxin fragment C
and cholera toxin B subunit [23]. In addition, neural stem cells
and neural progenitors have been isolated from human brain using
genetic promoter-reporters of neural stem cell markers [24,25].
Likewise, advancements have been made in the identification
and isolation of hESC-derived neural cells by FACS. Pruszak et al.
(2007) reported that cultures of hESC differentiating to neural
lineages can be assayed at different developmental stages with cell
surface markers and that neurons could be enriched using an
antibody to CD56 (NCAM) [26]. CD184
+/CD326
2 have been
used to purify neural progenitors capable of differentiation into
neurons from differentiating hESC [27]. In addition, Peh et al.
have reported the enrichment for neurosphere-forming NSC from
neural induction cultures of hESC based on expression for
CD133, CD15 and GCTM-2 [28]. Using a similar strategy,
Golebiewska et al. used CD133
+/CD45
2/CD34
2 to isolate NSC
from differentiating hESC [29]. Pruszak et al. (2009) demonstrated
the utility of CD24, CD15 and CD29 as a surface maker code for
isolating distinct cell populations, including NSC and a mixed
population of neuroblasts and neurons from neural induction
cultures of hESC [30].
These studies have made significant progress, but there is still a
need to develop improved methods for the purification of neural
cell types. Here we aimed to identify cell surface signatures that
would permit the isolation of NSC, glia and post-mitotic neurons
from neural differentiation cultures of pluripotent stem cells by
FACS. To this end, we performed an unbiased FACS- and image-
based screen, utilizing 190 characterized antibodies to cell surface
markers on multiple hESC-derived cell cultures. From this screen
we identified a cell surface signature that was successful in
enriching NSC from multiple common neural induction culture
systems. In addition, we identified cell surface signatures for the
isolation of neurons and glia from differentiating NSC cultures at
very high purity. Furthermore, we validated these methods on a
number of hESC and hiPSC lines.
Results
Antibody screens identify prospective markers for
distinguishing NSC, neurons and glia
We used the serum-free embryoid body (SFEB) culture method
with the H9 hESC line to generate cell populations for a FACS-
and image-based antibody screen (Fig. 1A). As previously reported
SFEB robustly generated heterogeneous cultures containing neural
ectoderm in the form of neural rosettes after plating EBs in
adherent plates, referred to here as EB-rosette(+) [31,32]. Neural
rosettes exhibited Sox1 staining (Fig. S1A), suggesting that they
were rich in NSC. Similar to previous results, we were able to
manually isolate a population of NSC from EB-rosette(+) capable
of subsequent expansion and differentiation to neurons and glia
[11,33]. Manually isolated NSC expressed neural stem cell
markers Sox1, Pax6, Sox2 and Nestin, although Pax6 expression
waned at later passages (Fig. S1B–E and data not shown). NSC
could be induced to differentiate to mixed cultures of neurons, glia
and undifferentiated NSC (Fig. S1F and data not shown). We
observed that this method for generating NSC was not always
successful, due to the inconsistent appearance of contaminating
cells that outgrew NSC in many cultures (NSC contaminants)
(Fig. S1H–J). Similar cell contaminants have been observed by
others (Alysson Muotri and Mark Tomishima, personal
communications).
We performed an unbiased FACS- and image-based screen
using a collection of 190 characterized monoclonal antibodies to
cell surface markers on cell cultures at distinct phases of neural
induction by SFEB: naı ¨ve hESC, EB-rosette(+), manually picked
and expanded NSC, and NSC that had been differentiated for 3
weeks to mixed populations of neurons and glia (Fig. 1, Fig. S2).
To identify markers of potentially contaminating cell types, we
screened a cell culture enriched in the NSC contaminant that
overgrew during a preparation of NSC and a cell culture of EB
that were depleted of neural ectoderm (EB-rosette(-)) (Fig. S1K).
We screened all of the cell populations by FACS except for the
differentiated NSC, which we screened by image to take
advantage of the distinct morphological differences between
neurons and non-neuronal cells. We co-stained these cultures
with anti-b-III tubulin to identify neurons (data not shown). ‘‘Hits’’
identified from the screens were verified by FACS (Fig. 1C, E).
CD184
+/CD271
2/CD44
2/CD24
+ enable the isolation of
NSC from neural induction cultures of pluripotent stem
cells
From our FACS screen we hypothesized that CD184
+/
CD271
2/CD44
2/CD24
+ could be used for isolating a population
of NSC from neural induction cultures while excluding hESC,
NSC contaminants, EB-rosette(2) and CD271
+ neural crest stem
cells [34,35] (Fig. 1B, C). We chose CD184 as a positive marker as
it was not expressed in hESC but was expressed in NSC and
identified a distinct subpopulation in EB-rosette(+). CD271 and
CD44 were convenient negative markers as they were expressed
on the majority of hESC, NSC contaminants and cells in the EB-
rosette(2) culture. CD271 also provided the added advantage of
removing neural crest. The cell sorting strategy used is depicted in
Fig. 2A. Similar to ‘‘good’’ preparations of manually isolated NSC,
these cultures were often free of NSC contaminants and could be
cultured in vitro for multiple passages (up to 22 tested). Image
and/or intracellular FACS analysis demonstrated that sorted cells
were negative for Oct3/4 and were highly enriched for cells
expressing Sox1, Sox2, Pax6 and Nestin (Fig. 2B–F). CD184
+/
CD271
2/CD44
2/CD24
+ cells could be induced to differentiate
to heterogeneous populations of neurons, glia and undifferentiated
NSC. Image analysis revealed expression of neuronal markers b-
III tubulin, Map2b and synaptophysin; the NSC marker, Nestin
and the proliferation marker Ki-67 (Fig. 2G–J). Similar to
manually isolated NSC, GFAP-immunoreactive astrocytes were
only observed after 1 month of differentiation (Fig. 2I).
We tested whether the CD184
+/CD271
2/CD44
2/CD24
+
signature applied to other cell lines and neural induction
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SFEB neural induction cultures of a hiPSC line, NDC3.1. These
cells exhibited similar qualities to those derived from H9. They
expressed Sox1, Pax6, Sox2 and Nestin, and they were positive
for Ki-67 (Fig. S3A–C). We isolated NSC from H9 SFEB cultures
or monolayer differentiation cultures that were treated with
recombinant noggin and the SMAD inhibitor SB431542 [4,8].
The percentage of CD184
+/CD271
2/CD44
2/CD24
+ cells in
SMAD-inhibited monolayer cultures was similar to SFEB
cultures (10-15% of total), whereas combined dual SMAD
inhibition with SFEB led to an increase in this NSC population
(,25% of total) (Fig. S3D,E and data not shown). We were also
successful in isolating NSC derived from a hiPSC line, NDC3.1,
and the hESC line HUES-9 from stromal derived induction
activity (SDIA) neural induction cultures using the PA6 mouse
stromal cell line [6,7,36]. These cells expressed Sox1, Pax6, Sox2
and Nestin (Fig. 2K–P). In some experiments, NSC isolated from
SDIA cultures were resorted after the first passage to remove
NSC contaminants that spontaneously appeared (data not
shown). This problem was most common with HUES-9. NSC
contaminants were usually not observed in resorted cultures 10
passages after resorting (data not shown).
We tested whether CD184
+/CD271
2/CD44
2/CD24
+ selected
for all of the NSC in neural induction cultures by sorting the cells
excluded by CD184
+/CD271
2/CD44
2/CD24
+, and analyzing
them for expression of the neural stem cell markers Sox1, Sox2
Figure 1. Cell surface marker screen of cell cultures at distinct phases of SFEB neural induction of H9 hESC. (A) Diagrammatic
representation of the SFEB neural induction and isolation of NSC (see Methods for details). EB = embryoid body(ies); EB-rosette(+) = EB at a stage of
differentiation when columnar rosettes are present in many EB; NSC = neuronal stem cells expanded from rosettes that were handpicked from EB-
rosette(+); NSC contaminant = culture of intermittent contaminant of handpicked and expanded NSC cultures. (B) Heat map showing percent
positive (% +ve) of representative cell surface markers in a FACS-based screen. EB-rosette(-) = EB depleted of rosettes. Markers identified from the
screen to be potential positive (pos) or negative (neg) selection candidates (Hits) are noted. (C) Examples of intensity distributions of EB-rosette(+)
cultures stained with candidate cell surface markers. The percentage reflects the population in the ‘‘positive’’ population for each marker. (D)
Examples of an image screen of cell surface markers on neuron enriched cultures induced to differentiate from NSC for 3 weeks. CD24 clearly stains
neurons whereas CD44, and CD15 do not. CD184 appears to stain some neurons and other cell types. (E) Same as c but with neuron-enriched cultures
induced to differentiate from NSC. Scale bar is 50 mm.
doi:10.1371/journal.pone.0017540.g001
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+/
Sox2
+/Pax6
+ cell subpopulation in the excluded cells from H9
SFEB cultures. Similar trends were observed for HUES-9 and
NDC3.1 SDIA neural induction cultures (data not shown). These
data indicate that CD184
+/CD271
2/CD44
2/CD24
+ selects for a
subpopulation of NSC rather than all of the NSC from
heterogeneous neural induction cultures.
We tested whether CD184
+/CD271
2/CD44
2/CD24
+ NSC
maintained expression of NSC markers and maintained neuro-
genic potential after multiple passages in culture (Fig. S4).
Intracellular FACS analysis demonstrated that CD184
+/
CD271
2/CD44
2/CD24
+ cells derived from H9, HUES-9 and
NDC3.1 expressed high levels of Sox2 and Nestin at passages 19,
22 and 16, respectively (Fig. S4A–C). CD184
+/CD271
2/
CD44
2/CD24
+ NSC derived from H9 maintained neurogenic
potential up to 22 passages tested (Fig. S4D). We counted 100
DAPI-positive cells for 3 replicates of passage 22 cells differen-
tiated for 3 weeks. We found that 42 (+/210) percent of the cells
were b-III tubulin positive. We also assessed neuronal differen-
tiation in passage 19 NSC derived from H9 by intracellular
FACS (Fig. S4E). Neurons could be identified by a Sox2
2/
Nestin
2/LOW population that expressed the neuronal marker
doublecortin (DCX), but did not express Ki-67, and were found
in similar numbers compared to image quantification. Image
analysis of differentiated HUES-9 NSC revealed expression
GFAP-positive astrocytes and neurons expressing the mature
neuronal markers Map2a/b, synapsin and GABA (Fig. S4F-I).
We quantified the percentage of differentiated HUES-9 NSC
committed to the neuronal fate by counting b-III-tubulin positive
cells. We counted 100 DAPI-positive cells from two different
experiments with two biological replicates. 31 (+/27) percent
were b-III-tubulin positive. We also assessed the percentage of
neurons in differentiated NDC3.1 NSC cultures by intracellular
FACS and observed similar trends (Fig. S4J). Mature oligoden-
drocytes, based on both marker expression and morphology, were
not detected in our in vitro NSC differentiation cultures (data not
shown).
We performed a clonal assay to evaluate if a single NSC could
give rise to a multipotent NSC population (Fig. S4K–N).
CD184
+/CD271
2/CD44
2/CD24
+ NSC derived from NDC3.1
were sorted into 96 well plates at one cell per well on a feeder
layer of mitotically inactivated mouse astrocytes to improve the
survival of the single cells. We observed colonies of 20 cells or
more appearing between 2-3 weeks after plating (data not shown).
The subcloning efficiency was 3 percent. The clonal cell
population expressed Sox2 and hNA (Fig. S4K). We differenti-
ated the cells for 3 weeks after clones were visible to determine if
they could give rise to neurons and glia (Fig. S4L–N). We
observed co-localization of hNA with both GFAP and b-III
tubulin, demonstrating that CD184
+/CD271
2/CD44
2/CD24
+
cells are multi-potent NSC.
CD184 and CD44 define a cell surface marker signature
for the purification of neurons and a glial cell population
from differentiating NSC cultures
From the imaging screen of differentiated NSC and subsequent
hit verification by FACS, we predicted that CD184
2/CD44
2/
CD15
LOW/CD24
+ would identify a population of neurons,
whereas CD184
+/CD44
+ would identify a population of glia.
CD184 was expressed in the processes of some neurons but not in
the cell bodies as previously reported in human fetal neural
progenitor differentiation [37] (Fig. 1D,E). As processes are
cleaved during the process of obtaining a single cell suspension,
the CD184-positive signal is lost from the majority of the neurons.
CD44 has been shown to be a marker of both glial progenitors and
astrocytes in many species; therefore, we hypothesized that the
CD44 subpopulation in our cultures contained these cell types
[16,38,39]. CD15 and CD24 were added to the neuronal sorting
strategy for confirmation and further refinement of the population.
Figure 3A illustrates the cell sorting strategy we employed in our
experiments. We isolated CD184
2/CD44
2/CD15
LOW/CD24
+
cells and CD184
+/CD44
+ cells simultaneously from cultures of H9
NSC (sorted from SFEB cultures) that were differentiated for 3
weeks. Two days post-FACS the CD184
2/CD44
2/CD15
LOW/
CD24
+ cell population was largely composed of neurons that
expressed Map2b and contained few cells expressing Nestin, Sox2
or Ki-67 (Fig. 3B,C). At 7 days post-FACS, the majority of the cells
were b-III tubulin-, Map2b-positive polarized neurons with
extensive arborized processes (Fig. 3D). This cell population was
devoid of GFAP-expressing astrocytes, and few Nestin-positive or
Ki-67-positive cells could be observed (Fig. 3D,E). Some sorted
neurons expressed the neuronal markers tyrosine hydroxylase,
GABA and synaptophysin, suggesting that mature neurons were
present in these cultures (Fig. S5D-F). Similar results were
obtained from sorting comparable differentiated NSC cultures
derived from HUES-9 and NDC3.1, as described in Figure 2 and
Figure S3 (Fig. 3F,G and data not shown).
To assess the purity of CD184
2/CD44
2/CD15
LOW/CD24
+
sorted neurons, we quantified expression of b-III tubulin, Nestin
and Ki-67 7 days post-FACS by image analysis. We quantified 3
experiments from differentiated NSC derived from H9, HUES-9
and NDC3.1. We counted 3 random fields; 300 DAPI positive
cells were counted for each experiment. The means for b-III
tubulin, Nestin and Ki-67 for the 3 experiments were 98 (2/+ 1),
1.6 (2/+ 1) and 0.6 (2/+ 0.9) percent, respectively.
Similar to neurons in unsorted cultures, sorted neurons were
electrophysiologically active. All of the cells tested had sodium and
potassium currents, and 6/8 of the cells patched fired action
potentials (Fig. 3H, I). Surprisingly, sorted neurons were modestly
viable without supporting cells and could be cultured in vitro for at
least 1 month with approximately 20–30% of the initial population
remaining (Fig. S5A–C). Moreover, sorted neurons could be co-
cultured with both human and mouse astrocyte cultures (Fig.
Figure 2. Sorting NSC from differentiating hESC and hiPSC from SFEB and SDIA neural induction cultures. (A) Cell sorting strategy of
NSC derived from H9 SFEB cultures at the EB-rosette(+) stage. Cells were first selected based on CD184 staining. The CD184
+ population was then
depleted of cells expressing CD271 and CD44. This cell population was nearly 100% positive for CD24 and contained cells expressing CD15. 10% of
the total cells (orange) were CD184
+/CD271
2/CD44
2/CD24
+. (B and C) Staining with anti-Sox1, anti-Pax6 and DAPI of CD184
+/CD271
2/CD44
2/CD24
+
H9 NSC from SFEB neural induction cultures at the third passage post-FACS. (D) Same as B but stained with anti-Sox2, anti-Nestin, and DAPI. (E and F)
Four color intracellular FACS analysis with anti-Sox1, anti-Nestin, anti-Sox2 and anti-Oct3/4 of CD184
+/CD271
2/CD44
2/CD24
+ H9 NSC from SFEB at
the third passage post-FACS. (G) CD184
+/CD271
2/CD44
2/CD24
+ H9 NSC expanded to passage 7 and induced to differentiate for 3 weeks and stained
with anti-Nestin, anti-b-III tubulin and DAPI. (H-J) The CD184
+/CD271
2/CD44
2/CD24
+ H9 NSC were differentiated for 3 weeks and stained with anti-
Map2b, anti-Ki-67 and DAPI; anti-GFAP, anti-synaptophysin (SYP) and DAPI. (K and L) Staining with anti-Sox1, anti-Pax6 and DAPI of CD184
+/CD271
2/
CD44
2/CD24
+ HUES-9 NSC from SDIA PA6 neural induction cultures at the fourth passage post-FACS. (m) Same as k but stained with anti-Sox2, anti-
Nestin and DAPI. (N-P) Same as K-M but with hiPSC, NDC3.1 NSC from SDIA PA6 neural induction cultures. Scale bar is 50 mm.
doi:10.1371/journal.pone.0017540.g002
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differentiated for 3 weeks in neuron differentiation medium prior to FACS. (A) Cell sorting strategy of differentiated H9 NSC using CD184
2/CD44
2/
CD15
LOW/CD24
+ and CD184
+/CD44
+. Similar populations were isolated from differentiated cultures of HUES-9 NSC and NDC3.1 NSC both derived
from SDIA PA6 co-culture. (B) Sorted CD184
2/CD44
2/CD15
LOW/CD24
+ cells were cultured in neuron differentiation medium for 2 days post-FACS and
subsequently stained with anti-Map2b, anti-Nestin, anti-Ki-67 and DAPI. White arrow indicates the presence of one Ki-67+, Nestin+ cell in this field. (C)
Isolation of Neural Cells Using Surface Markers
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method for generating highly pure populations of functional
neurons for downstream analysis under different culturing
conditions.
The CD184
+/CD44
+ population was isolated from differenti-
ated NSC cultures derived from H9, HUES-9 and NDC3.1
(Fig. 3J–M). At 7 days post FACS, this population appeared to be
homogeneous for Nestin-immunoreactive cells, with few, if any b-
III tubulin-positive neurons or GFAP-positive astrocytes (Fig. 3J
and Fig. S5k). Many of these cells expressed Ki-67, demonstrating
that they were mitotic (data not shown). At 14 days post-FACS,
neurons were absent but many GFAP-positive astrocytes were
observed (data not shown). These data suggested that the
CD184
+/CD44
+ population was restricted in its differentiation
capacity to glial lineages. When cultured in medium formulated
for astrocyte culture, robust GFAP expression could be observed 7
days post-FACS, further demonstrating their gliogenic potential
(Fig. 3K, L). We evaluated the fate of CD184
+/CD44
+ derived
from NDC3.1 after 6 passages in culture in astrocyte media. Image
analysis revealed that the majority of the cells expressed GFAP
(Fig. 3M). We subsequently cultured these cells in neuron
differentiation media for 2 weeks to determine if the cells had
potential to differentiate to oligodendrocytes and neurons, but did
not detect these cell types (data not shown). These data suggest
that the CD184
+/CD44
+ cell population is enriched in cells that
can mature to GFAP-expressing astrocytes.
Together, these data suggested that in differentiating cultures of
NSC, CD184
2/CD44
2/CD15
LOW/CD24
+ identified a popula-
tion of post-mitotic neurons and CD184
+/CD44
+ identified a
population of glia. To further assess the purity of these populations
we analyzed sorted cell populations by intracellular FACS for
Nestin and Ki-67 expression immediately after cell sorting (day 0
post-FACS) (Fig. 3N). We eliminated CD15 and CD24 from this
sort to allow for staining with these additional antibody conjugates.
In unsorted 3-week differentiation cultures of NSC we observed
Nestin
2/LOW and Nestin
+ populations. The Nestin
2/LOW popu-
lation was largely composed of quiescent cells, lacking Ki-67
expression [40], whereas the Nestin
+ population was largely
mitotic based on Ki-67 expression. Analysis of the sorted
populations revealed that the majority of the CD184
2/CD44
2
cells were Nestin
2/LOW/Ki-67
2 post-mitotic neurons and that the
CD184
+/CD44
+ cells were a near-homogeneous population of
mitotic Nestin
+ cells.
Survival, maturation and phenotype of spinally grafted
NSC populations
To assay functional engraftment abilities, HUES-9 SDIA cells
purified by sorting with the CD184
+/CD271
2/CD44
2/CD24
+
signature were transferred to differentiation conditions for 3 weeks
and the resulting cultures were transplanted as a single-cell
suspension into spinal ischemia-injured rats. The presence and
phenotype of grafted cells were analyzed 2 or 4 weeks after spinal
grafting. Double staining with human-specific nuclear antibody
(hNUMA) and anti-DCX, which stains immature post-mitotic
neurons, revealed numerous terminally differentiated grafted
neurons with extensive DCX-immunoreactive processes projecting
towards the ventral horn as well as medially and laterally in the
central gray matter (Fig. 4A–C; yellow arrows). No hNUMA or
DCX immunoreactivity was seen in animals injected with medium
only (Fig. 4D,E).
Confocal analysis of anti-hNUMA and anti-GFAP double-
stained sections revealed that numerous grafted cells were also
GFAP-immunoreactive and were typically localized at the
periphery of individual grafts (Fig. 4F; yellow arrows) and were
DCX-negative (Fig. 4G). Staining with anti-human specific Nestin
(anti-hNestin) revealed a subpopulation of grafted cells that were
Nestin-immunoreactive 2 weeks after grafting. These cells were
typically localized in the center of grafts and were DCX-negative
(Fig. 4H). At 4 weeks after grafting only occasional hNestin-
immunoreactive cells were identified. Staining with an antibody
for more mature human neurons, anti-human specific neuron-
specific enolase, showed no immunoreactivity in grafted cells after
2 or 4 weeks. Similarly, only occasional human-specific synapto-
physin staining was seen at this time point (data not shown),
indicating that grafted neurons were immature at this stage, which
is consistent with the observed intense DCX staining. To identify
proliferating cells, sections were stained with anti-Ki-67 and co-
stained with anti-hNUMA. Cells containing Ki-67 and hNUMA
reactivity were identified both in the core of the graft and the
periphery of the grafted area (Fig. 4I-K). Several Ki-67-positive,
hNUMA-positive cells were seen 2 weeks after grafting but fewer
were seen 4 weeks after grafting.
We next tested long-term engraftment and differentiation of
CD184
+/CD271
2/CD44
2/CD24
+ -sorted proliferating NSC.
Cells were expanded for 5-8 passages, grafted into lumbar spinal
segments in immunosuppressed ischemia-injured rats and animals
were sacrificed 8–10 weeks after grafting. In addition to DCX
staining sections were also stained with markers expressed in
mature neurons including human-specific enolase (hNSE) and
human-specific synaptophysin (hSYN). Similarly as for induced
NSC a high number of DCX immunoreactive grafted neurons
were identified at 10 weeks after cell transplantation (Fig. 5A). In
addition an intense hNSE and hSYN punctate-like immunoreac-
tivity was seen in grafted neurons (Fig. 5B-D) suggesting
substantial numbers of more mature neurons than seen at shorter
times after transplant. Co-staining with DCX and hNSE antibody
showed a subpopulation of grafted neurons co-expressing both
Same as B except cells were stained with anti-Sox2 instead of Ki-67. One Nestin+ cell is evident in this field. (D) CD184
2/CD44
2/CD15
LOW/CD24
+
sorted cells were cultured in neuron differentiation medium for 7 days post FACS and subsequently stained with anti-b-III tubulin, anti-Map2b, anti-Ki-
67 and DAPI. No Ki-67+ cells are observed in this field. (E) Same as D but stained with anti-b-III tubulin, anti-Nestin, anti-GFAP and DAPI. No GFAP+
cells are evident and one Nestin+ cell is evident in this field. (F) Same as E but from HUES-9. (G) Same as E but from hiPSC, NDC3.1. (H) Electrical
recordings of patched neurons from a 3-week differentiated HUES-9 NSC culture. All cells exhibited Na
+ current (right panel). 7 of 8 cells tested fired
action potentials when depolarized with current (left panel). (I) Electrical recordings of sorted neurons from a 3-week differentiated HUES-9 NSC
culture. Sorted neurons were cultured for an additional 3 weeks prior to recording. All cells exhibited Na
+ current (right panel). 6 of 8 cells fired action
potentials when depolarized with current (left panel). (J) CD184
+/CD44
+ sorted cells derived from H9 were cultured in neuron differentiation medium
for 7 days post-FACS and stained with anti-b-III tubulin, anti-Nestin, anti-GFAP and DAPI. (K) Same as H except cells were cultured in astrocyte culture
medium for 7 days prior to imaging. (L) Same as K, but from HUES-9. (M) CD184
+/CD44
+ cells from NDC3.1 were cultured for 6 passages in astrocytes
medium and stained for GFAP and DAPI. Scale bar is 50 mm. (N) 2-color intra-cellular FACS analysis of NSC sorted from H9 and then induced to
differentiate for 3 weeks prior to sorting cell populations based on different combinations of CD184 and CD44 immunoreactivity. The unsorted
population is composed of a Nestin
+ population that is highly enriched for mitotic Ki-67
+ cells whereas the Nestin
2/LOW population is quiescent.
Sorting of a CD184
2/CD44
2 population enriches for Nestin
2/LOW quiescent cells. Isolation of CD184
+/CD44
+ and CD184
+/CD44
2 cells enriches for the
Nestin
+ cycling population. Percentages for these 2 populations are indicated.
doi:10.1371/journal.pone.0017540.g003
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maintain their neurogenic potential after in vivo grafting and show
progressive expression of markers that are characteristics of
mature neurons. Staining with NG2 and Olig 2 suggest that a
subpopulation of grafted cells acquired an oligodendrocyte
phenotype (Fig. 5F–I).
To test glial differentiation, we assessed the ability of CD184
+/
CD44
+ cells to engraft in transgenic SOD1 mutant rats, where
transplantation of glial progenitors has been shown to be
neuroprotective [41]. Analysis of spinal cord sections 2 weeks
after grafting and stained with anti-hNUMA and anti-GFAP
showed numerous GFAP-positive grafted cells (Fig. 5J; yellow
arrows). No DCX-immunoreactive cells were observed (Fig. 5K).
Staining with anti-hNestin revealed the presence of numerous
hNestin-positive cells in the core of the graft at 2 weeks after cell
grafting (Fig. 5L). Costaining with anti-hNUMA and anti-Ki-67
revealed the presence of some proliferating grafted cells (Fig. 5M–
O). These data demonstrate that CD184
+/CD44
+ cells can
differentiate to astrocytes in vivo.
We also tested the ability of CD184
2/CD44
2/CD15
LOW/
CD24
+ neurons to engraft in spinal ischemia-injured rats (data not
shown). In 2 separate experiments we observed poor engraftment
by evidence of inflammation and dead cells. These results are
consistent with previous findings that show superior survival of
grafted fetal brain tissue or embryonic tissue-derived neural or
neuronal precursor cell lines [42,43,44,45].
Figure 4. Spinal transplantation of differentiated NSC cultured cells in rats with spinal ischemic injury. (A) In animals with previous
ischemic injury hNUMA+ grafted cells (blue) were identified in the intermediate zone or in the ventral horn (VH) 2 weeks after grafting. Scale bar is
100 mm. (B, C) Numerous hNUMA+ cells were DCX immunoreactive and showed extensive projection of DCX+ processes towards the ventral horn
(yellow arrows). Scale bar is 40 mm. Yellow dotted box represents expanded view in C. (D, E) In control animals injected with medium only, no hNUMA
or DCX immunoreactivity was identified. (F, G) A subpopulation of grafted hNUMA-positive cells showed colocalization with GFAP but were DCX-
negative (yellow arrows). Scale bar is 10 mm. (H) At 2 weeks after grafting hNestin-positive cells were seen in the core of the graft and were DCX
negative. Scale bar is 20 mm. (I–K) Proliferating cells were identified by colocalization of Ki-67 and hNUMA immunoreactivity and were primarily seen 2
weeks after grafting. Scale bar is 20 mm.
doi:10.1371/journal.pone.0017540.g004
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studies need to be performed to assess precisely the tumor-forming
potential of the cells we purify, our initial results demonstrate that
no tumor-like structures or clusters of aberrant-proliferating cells
were identified in any animal grafted with proliferating or
differentiated NSC cultures or glia. To date we have analyzed
more than 40 transplanted immunosuppressed Sprague-Dawley
rats or immunodeficient rats and 6 immunosuppressed minipigs
surviving for up to 3 months after cell grafting. No tumor
formation was observed in any of these animals. These data
indicate that CD184
+/CD271
2/CD44
2/CD24
+ NSC isolated
from pluripotent stem cells represent a source of NSC that may be
safer and thus useful in cell replacement strategies.
Discussion
We discovered a set of cell surface signatures that enable the
isolation of NSC, neurons and glia derived from neural induction
cultures of pluripotent stem cells. Figure 6 illustrates a schematic of
our cell sorting methods. An important advantage of our approach
is that it enables more consistent NSC preparations by allowing for
the isolation of NSC without manual dissection of rosettes. In
addition, the sorted glial cells provide a population of replicating
astrocytes that can be subsequently cultured in vitro. Most
importantly, our approach allows for the isolation of near-pure
populations of terminally differentiated neurons that are viable in
culture. In addition to cell sorting, these cell surface signatures can
also be used to comparatively analyze cell populations. In addition,
to the hits we further analyzed, there are many additional markers
from our data set to explore that could potentially identify unique
subpopulations of NSC, neurons and glia.
Our unbiased screen suggests novel uses of known markers for
the isolation of neural cell types. CD184
+ has been described for
the isolation of neural cells capable of differentiating to neurons
post-FACS [27]. We observed that CD184 negative selection, not
positive selection was required for isolation of post-mitotic
neurons. Another study reported the enrichment of hESC-derived
neurons by isolating CD56
+ neurons by FACS, but purity was not
described [26]. Based on our screening data, CD56
+ would not
adequately discriminate against non-neuronal cells. Pruszak et al.
(2009) performed a cell surface marker analysis on expanded and
differentiated neural rosettes and reported that CD29, CD15 and
CD24 defined distinct cell types within this cell population [30].
They described multiple populations based on CD24 immunore-
activity, which we did not observe, possibly due to the differences
in the maturation of the neural induction cultures used. It will be
interesting to determine the relationship of their signatures to those
described here. CD133 has proven useful for isolating NSC in
multiple studies [28]. We avoided CD133 as a selection marker for
NSC due to its high expression in hESC and dim expression in
EB-rosette(+) cultures in our screens, which raises the risk of
insufficient purification away from pluripotent stem cells. In
addition to neural ectoderm, CD184 and CD15 have been shown
to mark and isolate progenitors from other germ layers
[46,47,48,49]. Since we could not examine all possible differen-
tiation methods, more work is needed to determine whether the
Figure 5. Spinal transplantation of proliferating NSC cultured cells in rats with spinal ischemic injury. (A) At 10 weeks after grafting a
high density of DCX+ grafted neurons (red) in the center of intermediate zone were identified. Numerous solitary DCX+ neurons which migrated into
ventral horns (yellow arrows) were also seen. Scale bar is 100 mm. (B, C) High density of hSYN punctata-like immunoreactivity in the regions
containing grafted DCX+ neurons was seen. (D) hSYN immunoreactivity showed spatial co-localization with DCX+ processes (yellow arrows). Scale bar
is 20 mm. (C-insert, E) Numerous hNSE immuoreactive neurons in the core of grafted regions were identified (yellow arrows). Scale bar is 20 mm. (F–I)
A subpopulation of grafted cells acquired an oligodendrocyte phenotype and were NG2 or Olig2 immunoreactive. Scale bar is 20 mm. (J, K)
Transgenic SOD1 mutant rats were grafted with CD184
+/CD44
+ sorted glial cells derived from differentiated HUES-9 NSC cultures. Numerous hNUMA/
GFAP-positive astrocytes were identified in the core of the graft 2 weeks after grafting but no DCX-positive neurons were seen. Scale bar is 20 mm. (L)
2 weeks after grafting numerous hNestin-positive cells typically localized in the core of the graft. Scale bar is 20 mm. (M–O) Costaining with hNUMA
and Ki-67 antibody revealed occasional proliferating cells (yellow arrow). Scale bar is 20 mm.
doi:10.1371/journal.pone.0017540.g005
Figure 6. Diagram of stages and defined markers for isolation
of NSC, neurons and glia from neural induction cultures
starting with pluripotent stem cells.
doi:10.1371/journal.pone.0017540.g006
Isolation of Neural Cells Using Surface Markers
PLoS ONE | www.plosone.org 10 March 2011 | Volume 6 | Issue 3 | e17540signatures described here are sufficient for isolating neural cell
types in additional in vitro differentiating cell culture systems.
Additional negative selection markers may be necessary for
discriminating other cell types from very heterogeneous cell
cultures. For example, Flk-1 may be useful for excluding
mesodermal cells [46]. Comparison of our data set to those of
subsequent immunophenotyping screens on endodermal and
mesodermal cell lineages may ultimately lead to appropriate cell-
surface signatures for desired cell types in any culture condition.
We believe that immunophenotyping screens could be per-
formed in higher throughput and greater complexity. For
example, it may be possible to take advantage of advances in
fluorescent cell bar-coding to enable immunophenotyping of
multiple cell cultures simultaneously in one experiment [50]. We
were successful in correlating neuronal b-III tubulin staining with
cell surface markers by image analysis. It may be possible to
combine cell-surface immunophenotyping with intracellular FACS
analysis to identify cell-surface signatures of specific cell types and
subpopulations therein. This type of analysis could be instrumental
in defining cell surface marker signatures for different develop-
mental stages in neural induction and regional specification, as
well as for specific cell subtypes such as dopaminergic neural
progenitors and neurons.
Our grafting studies of 3-week differentiation cultures of
CD184
+/CD271
2/CD44
2/CD24
+ HUES-9 NSC revealed a
time course of neuronal and glial maturation and a clear
population of grafted DCX-positive neurons or GFAP-positive
astrocytes identified 2-4 weeks after grafting, consistent with our
previous studies [45,51,52]. No hNSE or human specific
synaptophysin (hSYN) expression was seen at 4 weeks. In contrast,
intense hNSE and hSYN immunoreactivity was seen 8–10 weeks
after grafting of proliferating NSC, similar to the neuronal
maturation profile of proliferating human fetal spinal neural
precursors grafted spinally in the same spinal-ischemia model or in
naı ¨ve immunosuppressed minipig in earlier studies [45,53]. In
addition, a subpopulation of grafted proliferating NSC acquired
oligodendrocyte phenotype as evidenced by expression of NG2
and Olig2. In contrast to long-term survival and maturation of
grafted differentiated or proliferating NSC, no survival of
CD184
2/CD44
2/CD15
LOW/CD24
+ purified neurons was seen
at 2 or 4 weeks after grafting. These data suggest that
transplantation of proliferating CD184
+/CD271
2/CD44
2/
CD24
+ NPC is sufficient for long-term neuronal engraftment
without tumor formation.
In transgenic SOD1 mutant animals grafted with CD184
+/
CD44
+ glia, no DCX-immunoreactive neurons were identified
and the majority of grafted cells expressed GFAP, similar to our
long term in vitro culture. More extensive studies need to be
performed to determine whether CD184
+/CD44
+ sorted glia have
potential to differentiate to oligodendrocytes, but at this time they
appear to be highly enriched for cells that can give rise to
astrocytes.
While we observed cells that expressed oligodendrocyte markers
10 weeks after grafting, we did not observe convincing staining with
these markers our in vitro cultures. This difference could be niche
and/or time dependent. Others have reported spurious oligoden-
drocyte differentiation of hESC-derived NSC in vitro [11]. We
suspect that significantly longer culture times and/or different
differentiation conditions may be required to achieve mature
oligodendrocyte differentiation in vitro [54]. It is also possible that
the CD184
+/CD271
2/CD44
2/CD24
+ NSC subpopulation is
more biased to neuronal and astrocyte differentiation.
Our approach to defining cell surface signatures in differenti-
ating cultures of pluripotent human stem cells will potentially
enable quantitative benchmarks to be devised for comparing
specific cell populations generated by different hESC and hiPSC
lines. In addition, further antibody screens may yield cell surface
signatures of specific neuronal and neural progenitor subtypes as
well as signatures of desired cell types from other germ layers. For
applications such as transplantation, our approach will be very
useful for obtaining pure, well-defined cell populations. Finally,
these methods are applicable to many studies of the characteristics
of defined neuronal populations, expression analyses, generating
defined mixtures of cell types to test disease models for non-cell-
autonomous phenotypes, and for drug testing and development.
Methods
Ethics Statement
This study was approved by the University of California, San
Diego (UCSD) Internal Review Board (IRB), approval ID#
100887. Written consents were obtained prior to biopsy for all
research uses.
hESC culture
For feeder growth conditions, H9 (WiCell) hESCs were cultured
and maintained according to the methods recommended by
WiCell. Briefly cells were cultured on a irradiated mouse
embryonic fibroblast (MEF) feeder layer in DMEM:F12, 20%
Knockout Serum Replacement (KOSR), non-essential amino
acids, 20 mM glutamine (all from Invitrogen), penicillin/strepto-
mycin (Lonza), bFGF (BD). Cells were passaged using collagenase
IV (Invitrogen). For feeder-free growth conditions, H9 cells were
cultured in mTeSR1 maintenance medium (Stem Cell Technol-
ogies) on Matrigel-coated plates and passaged with Dispase (BD).
HUES-9 were cultured according to the method described in
Cowan et al [2]. Briefly, HUES-9 were maintained on a MEF
feeder layer in HUES hESC medium containing Knockout-
DMEM (Life Technologies), 10% plasmanate, 10% KOSR, non-
essential amino acids, 20 mM glutamax, penicillin/streptomycin
(all from Invitrogen), 10 ng/ml bFGF (R&D Systems). Cells were
passaged with Trypsin.
Generation and culture of hiPSC
Adult human skin biopsies were obtained from volunteers at the
Alzheimer’s Disease Research Center, University of California,
San Diego. Adult human dermal fibroblasts were transduced with
retroviruses encoding Oct3/4, Klf4, Sox2, c-Myc overnight. On
day 3, the transduced fibroblasts were treated with 20 mM VPA
(Sigma) for 7 days. On day 4, the fibroblasts were plated onto a
MEF feeder layer with HUES hESC medium. The colonies were
picked at 2 weeks when visible. They were initially passaged by
mechanical dissociation and subsequently adapted to Trypsin
(Invitrogen). HiPSC lines were characterized for their ability to
differentiate into cells of the 3 germ layers and for the expression of
biomarkers for pluripotency.
Neural induction by SFEB
Neural induction was performed essentially as previously
described [10]. Briefly, hESC were treated with dispase 1 mg/
ml for 10 minutes. The colonies were lifted off and washed with
fresh WiCell hESC medium without FGF. Cells were transferred
to low adherence culture dishes in WiCell hESC medium without
FGF. After 4 days in culture, EBs were plated on matrigel-coated
(BD Biosciences) plates in ITS medium: DMEM:F12 (Life
Technologies), ITS supplement (Sigma) and penicillin/streptomy-
cin (Lonza) for about 16 days. At this point, columnar rosette
structures were either manually isolated and passaged every other
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sorted from this heterogeneous cell population. In some experi-
ments, 500 ng/ml recombinant Noggin (R&D Systems) and
10 mM SB431542 (Tocris) were added at the onset of the
experiment and continued through day 10 in ITS medium.
Generation of EB that are depleted of neural ectoderm
(EB-rosette(-)) and NSC contaminant
HESC H9 colonies were scraped from their substrate and cell
clumps were triturated to small pieces with a pipette. Cells were
cultured in low-adherence plates in DMEM:F12, 20% FBS for 1
week and plated on matrigel-coated plates in the same medium for
an additional 2 weeks. Under these conditions few rosettes were
observed, with many EB demonstrating islands of loose endothe-
lial-like cells and large vacuoles. NSC contaminants were
generated from a failed attempt to manually isolate NSC from
SFEB.
Cell surface antibody screen
Antibodies to human cell surface markers were lyophilized in
96-well plates at 0.5 mg/well with the exception of CD133 (similar
plates are commercially available from BD Biosciences; see Fig. S2
for antibodies used and clone names. For screening by flow
cytometry, cells were dissociated with Accutase (Innovative Cell
Technologies) and resuspended in BD Pharmingen Stain Buffer
(BD Biosciences) with the addition of 5 mM EDTA. Cells were
dispensed into 96-well round bottom plates (BD Biosciences) at
160,000 to 500,000 cells per well. Antibodies were reconstituted
with 1X PBS and cells were stained live on ice for 20 minutes.
Cells were washed with Stain Buffer and then stained with APC
goat-anti-mouse IgG secondary antibody (BD Biosciences) for 20
minutes. Cells were washed and analyzed on a LSRII HTS system
(BD Biosciences). Data were analyzed with FlowJo software and
Microsoft Excel 2007 for generation of heat maps. For
immunophenotyping by bioimaging, cells were cultured on 96-
well bioimaging plates (BD Biosciences). Antibodies were recon-
stituted in NSC differentiation medium and cells were stained live
on ice for 20 minutes. Cells were washed and then stained with an
Alexa FluorH 647 goat-anti-mouse IgG secondary antibody
(Molecular Probes) for 20 minutes. Cells were washed, fixed with
4% paraformaldehyde, washed and imaged on a BD Pathway 435
confocal bioimager.
Neural induction by dual SMAD inhibition on monolayer
cultures
H9 hESC were grown in mTeSR1 medium on matrigel-coated
plates and passaged as single cells with Accutase (Innovative Cell
Technologies). When cultures became 100% confluent, medium
was changed to ITS medium with the addition of 500 ng/ml
Noggin and 10 mM SB431542 for 7 days. Cells were collected by
gently scraping monolayers. Cell clumps were collected and
replated on matrigel-coated plates in ITS medium. At day 12
medium was replaced with NSC growth medium 2 (see below) for
3 days before sorting.
PA6 differentiation/SDIA
PA6 cells were plated in a 10 cm dish at 1:5 from a confluent
dish. The next day, HUES-9 were plated onto the PA6 cells at
100,000 cells/ml in PA6 differentiation medium: Glasgow
DMEM, 10% KOSR,1 mM Sodium Pyruvate, 0.1 mM Nones-
sential Amino Acids and 0.1 mM b-Mercaptoethanol (all from
Invitrogen). Medium was changed every 3–4 days, then daily after
day 10 for an additional 10 days. To enhance neural induction,
some cultures were treated with 500 ng/ml Noggin (R&D
Systems) and 10 mM SB431542 (Tocris) for 6 days starting on
the day of plating cells.
NSC culture
Manually isolated or sorted NSC were cultured on 20 mg/ml
poly-L-ornithine and 5 mg/ml laminin (both from Sigma) (POL)
coated plates. Two different NSC culturing media were used.
HUES-9 and hiPSC NSC were cultured in NSC growth medium
1: DMEM:F12+Glutamax, 0.5X N2, 0.5X B27, 1X P/S, 20 ng/
ml FGF. H9 NSC were cultured in NSC growth medium 2:
DMEM:F12+Glutamax, 1X N2, 1 ml/ml B27 (both from Life
Technologies), 20 mg/ml insulin, 1.6 g/l glucose (both from
Sigma), penicillin/streptomycin (Lonza), 20 ng/ml bFGF,
20 ng/ml EGF (both from BD Biosciences) [11]. In both cases,
media were changed every 2–3 days and cells were split with
Accutase (Innovative Cell Technologies).
NSC differentiation
NSC were seeded on POL plates in NSC growth medium for
HUES-9 and hiPSC and NSC growth medium 2 for H9. When
the dish was 70% confluent, medium was switched to neuron
differentiation medium: DMEM:F12+Glutamax, 0.5X B27, 0.5X
N2 (Invitrogen), 1X P/S (Lonza), 20 ng/ml BDNF, 20 ng/ml
GDNF (both from Peprotech) and 0.5 mM dibutyryl cyclic AMP
(Sigma) for 3 to 4 weeks. Medium was changed every 2-3 days.
Immunofluorescent imaging of cells in culture
Cells were fixed with 4% paraformaldehyde. Cells were either
permeabilized in 0.1% Triton or PermWash buffer (BD
Biosciences). See Table S1 for a list of primary purified and
fluorochrome-conjugates antibodies used and their dilutions.
Primary unconjugated antibodies were stained with secondary
antibodies goat anti-rabbit and goat anti-mouse conjugated to
Alexa 488, 647, 555; Molecular Probes). Cell nuclei were
counterstained with DAPI. Cells were imaged on a BD Pathway
435 confocal bioimager and analyzed with Attovision software (BD
Biosciences).
FACS – isolation of NSC from differentiating hESC and
hiPSC cultures
Cells were dissociated with Accutase (Innovative Cell Technol-
ogies) for 20-40 minutes. The cells were broken up by triturating.
Cells were washed once with PBS to remove the Accutase and
treated in NSC growth medium with 100 units/ml DNase (Sigma)
for 10 minutes at room temperature and strained through a 70 mm
cell strainer (BD Biosciences). Cells were washed and resuspended
in NSC sorting medium: NSC growth medium 1 or 2 with the
addition of 0.5% BSA and 5 mM EDTA. Cells were stained with
fluorochrome-conjugated antibodies for 20–30 minutes (see Table
S1 for antibodies and their dilutions). Cells were washed and
resuspended in NSC sorting medium at a concentration of 5
million cells/ml. Cells were sorted with a FACSAria II (BD
Biosciences) with a 100 mm nozzle at approximately 20 PSI and
cells were collected in NSC growth medium 1 or 2. Cells were
centrifuged and resuspended in fresh growth medium for plating.
FACS – isolation of neurons and glia from differentiating
NSC cultures
NSC were induced to differentiate in NSC differentiation
medium for 3–4 weeks. Cells were prepared the same as the NSC
except that NSC differentiation medium was used in place of NSC
growth medium. Sorted neurons and glia were plated at 100,000–
Isolation of Neural Cells Using Surface Markers
PLoS ONE | www.plosone.org 12 March 2011 | Volume 6 | Issue 3 | e17540200,000 cells per well in 96-well imaging plates (BD Biosciences)
coated with 20 mg/ml poly-l-ornithine and 0.25 mg/ml matrigel.
We found it crucial for sequential coating of these 2 substrates.
Sorted glia were cultured in NSC differentiation medium or
Astrocyte culture medium (Lonza), which expedited GFAP
expression.
Intracellular FACS analysis
Cells were dissociated with Accutase, washed with 1X PBS,
fixed with 4% paraformaldehyde and permeabilized with Perm/
Wash Buffer or Perm buffer III (both from BD Biosciences). Cells
were stained with flurochrome-conjugated antibodies for 20–30
minutes and washed with Perm/Wash Buffer or Stain buffer (if
permeabilized with Perm buffer III (BD Biosciences) (see Table S1
for antibodies and their dilutions). Background staining for
antibodies was determined in negative cell lines and with matched
flurochrome-conjugated isotype controls. Cells were analyzed on
an LSRII flow cytometry system (BD Biosciences).
Neuron viability Assay
Neurons were sorted and cultured as described above. Cells
were counted prior to plating. Four to 6 hours after plating cells
were harvested using Accutase and counted with a hemocytometer
using Trypan blue extrusion (Sigma) or a Vi-CELL analyzer
(Beckman Coulter). Percent recovery was determined by the cell
numbers recovered divided by the number of cells initially plated.
Clonal Analysis
CD184
+/CD271
2/CD44
2/CD24
+ NSC were dissociated with
Accutase to single cells and sorted one cell per well by FACS
ARIAII into a 96 well plate containing mitotically inactivated
mouse astrocytes. Floxuridine was used to inactivate the mouse
astrocytes. NSC growth medium with FGF was replenished every
other day.
Electrophysiology
Whole-cell perforated patch recordings were performed from
sorted HUES-9 NSC that were differentiated in neuron
differentiation medium for 3 weeks. The recording micropipettes
(tip resistance 4–8 MV) were tip filled with internal solution
(115 mM K-gluconate, 4 mM NaCl, 1.5 mM MgCl2,2 0 m M
HEPES, and 0.5 mM EGTA [pH 7.3]) and then back filled with
internal solution containing amphotericin B (200 g/ml). Record-
ings were made using an Axopatch 200B amplifier (Axon
Instruments). Signals were filtered at 2 kHz and sampled at
10 kHz. The whole-cell capacitance was fully compensated,
whereas the series resistance was uncompensated but monitored
during the experiment by the amplitude of the capacitive current
in response to a 5 mV pulse. The bath was constantly perfused
with fresh HEPES-buffered saline (115 mM NaCl, 2 mM KCl,
10 mM HEPES, 3 mM CaCl2, 10 mM glucose, and 1.5 mM
MgCl2 [pH 7.4]). For current-clamp recordings, cells were
clamped at a range of 260 to 280 mV. For voltage-clamp
recordings, cells were clamped at 270 mV. All recordings were
performed at room temperature.
Induction of spinal ischemic injury
Transient spinal cord ischemia (10 min) was induced as
previously described [55]. Briefly, a 2F Fogarty catheter (Am. V.
Muller) was passed through the left femoral artery to the
descending thoracic aorta to the level of the left subclavian artery
in isoflurane (1.5–2%)-anesthetized SD rats. Distal arterial
pressure (i.e., below the level of aortic occlusion) was monitored
by cannulation of the tail artery (PE-50). Spinal cord ischemia was
induced by inflation of the intra-aortic balloon catheter (0.05 ml of
saline) and concurrent systemic hypotension (40 mm Hg) induced
by blood withdrawal (10.5–11 cc into a heated (37uC) external
reservoir) via a 20-gauge polytetrafluoroethylene catheter in the
left carotid artery. The efficacy of the occlusion was demonstrated
by an immediate and sustained drop in distal blood pressure. After
10-min ischemia, the balloon was deflated, and the blood was
reinfused. Once the arterial blood pressure was stabilized (20–
30 min after reflow), the arterial lines were removed and wounds
closed. After ischemia, the recovery of motor function was assessed
in 2-day intervals using a 21-point open field locomotor scale [56].
Only animals with a score of 0-4 (i.e., corresponding with chronic
paraplegia) at 1–2 months after ischemia were used in the
transplantation study.
Preparation of differentiated NSC for spinal implantation
NSC cultures were induced to differentiate for 3 weeks in NSC
differentiation media. Cells were treated with Accutase (Innovative
Cell Technologies) for 20–30 min and a single cell suspension was
prepared by a repeated (10–15 times) trituration using a 10 mL
plastic pipette. The cell suspension was treated with a DNase
solution for 10 min. To remove cell debris, the cell suspension was
placed on an ovomucoid gradient (Worthington Biochemical
Corp) and centrifuged at 706g for 6 min. Cells were resuspended
in PBS and a viability test was performed using Trypan blue
extrusion test (Sigma). On average, a 75–90% viability rate was
recorded. The cell concentration was adjusted to a final
concentration of 7,000–10,000 viable cells in 0.5 ml. the cells were
stored at 4uC and used for implantation without further
manipulation. Just before spinal injections, the cell suspension
was aspirated into a glass capillary using a 50 ml Hamilton syringe.
Preparation of proliferating NSC for spinal implantation
Proliferating NSC cultures at 10–15 passages were treated with
Accutase (Innovative Cell Technologies) for 20–30 min and a
single cell suspension was prepared by a repeated (10–15 times)
trituration using a 10 mL plastic pipette. The pre-grafting cell
preparation was identical to that described for induced NSC.
Preparation of hESC-NSC-derived neurons for spinal
implantation
HUES-9 NSC cultures were induced to differentiate for 3 weeks
in neuron differentiation medium. CD184
2/CD44
2/CD15
LOW/
CD24
+ neurons were then sorted and cultured in presence of
cAMP, GDNF and BDNF for 1–2 weeks and then prepared for
grafting. The pre-grafting cell preparation was identical to that
described for induced NSC.
Preparation of hESC-derived glia for spinal implantation
in SOD+ rats
HUES-9 NSC cultures were induced to differentiate for 3 weeks
in neuron differentiation medium. Sorted CD184
+/CD44
+ cells
were cultured in NSC growth medium for 3 days before grafting.
The pre-grafting cell preparation was identical to that described
for differentiated NSC.
Spinal cord implantation of proliferating, differentiated
and sorted NSC populations
Animals were anesthetized with 1.5–2% isoflurane (in room air),
placed into a spinal unit apparatus (Stoelting) and a partial Th12–
L1 laminectomy was performed using a dental drill (exposing the
dorsal surface of L2-L5 segments). Using a glass capillary (tip
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injector (Stoelting), rats were injected with 0.5 ml of the
differentiated NSC in PBS. The duration of each injection was
60 s followed by 30 s pause before capillary withdrawal. The
center of the injection was targeted into the central gray matter
(laminae V–VII) (distance from the dorsal surface of the spinal
cord at L3 level: 1 mm) [52]. The rostrocaudal distance between
individual injections ranged between 300–500 mm. Animals
(n=4–7 for each cell population) received a total of 10 bilateral
injections (10 injections on the left and 10 injections on the right
side). After implantation, the incision was cleaned with 3% H2O2
and penicillin/streptomycin mixture and closed in 2 layers.
Immunosuppression
All animals were immunosuppressed with Prograf (FK506;
Astellas Pharma) in combination with Cellcept (mycophenolate
mofetil; Roche Pharmaceuticals). Treatment with both drugs
started one day before cell grafting. Prograf was injected at dose of
3 mg/kg/day i.p. for the first 14 days and the dose was lowered to
1 mg/kg/day and continued for the duration of study. Treatment
with Cellcept was initiated at a dose of 50 mg/kg/day i.p. for the
first 2 days and then the dose was decreased to 30 mg/kg/day.
Treatment with Cellcept was stopped at 7 days post-grafting.
Perfusion fixation, tissue processing and
immunohistochemistry
At the end of the survival periods, rats were terminally
anesthetized with pentobarbital (100 mg/kg; i.p.) and transcar-
dially perfused with heparinized saline (100 ml) followed by 4%
paraformaldehyde in 0.1 M phosphate buffer (PB; 500 ml). The
spinal cords were dissected and postfixed in the same fixative
overnight at 4uC. After postfixation, tissue was cryoprotected in a
graded sucrose solution (10, 20 and 30%). Frozen coronal spinal
cord sections (20–30 mm) were then cut.
Free-floating sections were incubated at 4uC with primary
antibodies (see Table S1 for antibodies and their dilutions). After
incubation with primary antibodies, sections were washed 3 times
in PBS and incubated with fluorescent-conjugated species-specific
secondary antibodies raised in donkey (Alexa 488, 546, 647
(Invitrogen, Carlsbad, CA). For multiple labeling experiments,
primary antibodies from different species were applied simulta-
neously, followed by application of secondary antibodies conju-
gated to different fluorescent markers. For general nuclear
staining, DAPI was added to the final secondary antibody
solution. After staining, sections were mounted on slides, dried
at room temperature and covered with Prolong anti-fade kit
(Invitrogen, Carlsbad, CA). Slides were analyzed with a Leica
(DMLB) fluorescence microscope and a Zeiss AxioCam MR
camera. Some images were captured with an Olympus Fluoview
1000 confocal microscope. All images were processed by Adobe
CS3 (Adobe Systems).
Supporting Information
Figure S1 Characterization of cells generated from
SFEB culture of H9. (A) Rosette at the EB-rosette(+) stage
stained with anti-Sox1 and DAPI. (B) Picked NSC expanded from
EB-rosette(+) were stained with anti-Sox1 and DAPI. (C) Same as
c but stained with anti-Sox2, anti-Nestin, and DAPI. (D, E) Four-
color intracellular FACS analysis with anti-Sox1, anti-Nestin, anti-
Sox2 and anti-Oct3/4 of NSC expanded from EB-rosette(+). (F)
NSC induced to differentiate for 3 weeks and stained with anti-
Nestin, anti-b-III tubulin and DAPI. (G-L) Bright field images of
(G) high quality NSC, (H) NSC that are crowded by contaminants
(white arrows = NSC, black arrow = contaminants), (I)
contaminants at low density, (J) contaminants at high density,
(K) EB-rosette(-) depleted of NSC that have been plated and
allowed to expand and (L) EB-rosette(+) illustrating columnar
rosette structures. Scale bar is 50mm for A-F, 100 mm for G-L.
(TIF)
Figure S2 Heat map depicting the results from the
FACS and image screens as well as subsequent verifica-
tion of imaging hits by FACS. The data are organized as
percent positive (% +ve) for FACS. Antibody specificity and clone
names separate the FACS and image data. EB-rosette(+)=E B
with rosettes; EB-rosette(-) = EB depleted of rosettes; NSC =
neuronal stem cell expanded from manually isolated EB-rosette(+).
NSC contaminant = culture of intermittent contaminant of
handpicked and expanded NSC cultures; Neurons and glia =
NSC that have been differentiated for 3 weeks and are composed
of mixed cultures of neurons, glia and undifferentiated NSC.
Images were classified as negative or too dim to determine (Neg/
dim) or apparent expression in neurons (pink), non-neuronal cells
(Other, blue), or both neurons and non-neuronal cells (Both,
purple). Selected hits from the imaging screen were analyzed by
FACS.
(TIF)
Figure S3 FACS and image data of sorted cells from
different neural induction methods. (A, B) Staining with
anti-Sox1, anti-Pax6 and DAPI of CD184
+/CD271
2/CD44
2/
CD24
+ NDC3.1 NSC from PA6 co-culture at the 4th passage after
the sort. (C) Same as (a and b) but stained with anti-Ki-67, anti-
Nestin, and DAPI. Scale bar is 50 mm. (D) Sorting of H9 after
SMAD inhibition with SFEB method. Note that the percentage of
likely NSC increases from 10 to 23%. Also CD44 + contaminants
are reduced. (E) Sorting of H9 after SMAD inhibition of cells as a
monolayer. (F) H9 SFEB cultures that were also treated with dual
SMAD inhibition were stained for CD184
+/CD271
2/CD44
2/
CD24
+ and the cells not selected by the signature were sorted and
analyzed for Sox1, Sox2 and Pax6 by intracellular FACS. The two
dimensional plot indicates the presence of Sox2
+/Sox1
+ cells (blue,
24.1% of total). The histogram demonstrates that the Sox2
+/
Sox1
+ cells are also positive for Pax6.
(TIF)
Figure S4 Characterization of long-term NSC cultures.
(A-C) Intracellular FACS analysis of NSC cultures: (A) hiPSC
NDC3.1 NSC at passage 16, (B) H9 at passage 19 and (C) HUES-
9 at passage 22. For these studies we used a new Sox2 antibody
that revealed two distinct Sox2 populations. (D) Immunofluores-
cent image of H9 sorted NSC passage 22 differentiated for 3 weeks
and stained with b-III tubulin and DAPI. (E) Intracellular FACS
analysis of H9 sorted NSC passage 19 differentiated for 4 weeks
with Nestin, Sox2, DCX and Ki-67. (F) Immunofluorescent
images of HUES-9 NSC passage 22 stained with anti-Sox2, anti-
Nestin and DAPI. (G) Immunofluorescent images of HUES-9
NSC passage 22 differentiated for 4 weeks and stained with anti-
GFAP and anti-Map2b and DAPI. (H) Same as G, but stained
with anti-b-III-tubulin, anti-synapsin and DAPI. (I) Same as G,
but stained with anti-GABA and DAPI. (J) Intracellular FACS
analysis of hiPSC NDC3.1 sorted NSC passage 16 differentiated
for 4 weeks with Nestin, Sox2, DCX and Ki-67. (K) Immunoflu-
orescent images of clonally derived NSC from hiPSC NDC3.1
sorted NSC with anti-human nuclear antigen (hNA), anti-Sox2
and DAPI. (L) Clonally derived NDC3.1 NSC were differentiated
for 3 weeks and stained with anti-hNA, anti-GFAP and DAPI.
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tion with hNA. White arrowhead indicates mouse astrocytes that
are large and appear more differentiated. (M) An enlargement of
the inset from l showing the GFAP+/hNA+ cells. (N) Same as L,
but stained with anti-hNA, anti-b-III-tubulin and DAPI. Scale bar
is 50 mm.
(TIF)
Figure S5 Culturing and viability of sorted neurons. (A)
Bright field images of sorted CD184
2/CD44
2/CD15
LOW/
CD24
+ H9 neurons at day 0, 4 and 8 post-FACS. (B) Viability
measurements of sorted neurons generated from H9 with the
SFEB method. On Day 0, neurons were sorted and counted before
plating and 6 hours after plating. Percent survival is measured by
the number of cells recovered divided by the number of cells
plated. Subsequent time points were taken as indicated. (C)
Viability measurements of sorted neurons generated from HUES-
9 with the SDIA PA6 co-culture method. Neurons were sorted on
Day 0 and counted before plating and 4 hours after plating. Time
points were taken as indicated. (D) CD184
2/CD44
2/CD15
LOW/
CD24
+ H9 neurons were stained with TH and DAPI. (E)
CD184
2/CD44
2/CD15
LOW/CD24
+ hiPSC NDC3.1 neurons
were stained with GABA and DAPI. (F) Same as D, but stained
with ant-Map2b, anti-synaptophysin and DAPI. (G) H9 sorted
neurons were co-cultured with human astrocytes for 14 days post-
FACS and stained with anti-b-III tubulin, anti-Map2b, anti-GFAP
and DAPI. (H) H9 sorted neurons were co-cultured with mouse
astrocytes for 7 days post-FACS and stained with anti-b-III
tubulin, anti-GFAP and DAPI. (I) HUES-9 sorted CD184
+/
CD44
+ glia cultured in neuron differentiation medium 7 days post-
FACS were stained with anti-b-III tubulin, anti-Nestin, anti-GFAP
and DAPI. Scale bar is 50 mm.
(TIF)
Table S1 Antibodies used for imaging and FACS. * The
antibody panel used was comprised of 189 antibodies to cell
surface markers and was the prototype of the product listed.
** Antibodies not commercially available at the time of
publication. *** Kind gift from William Stallcup, Sanford-
Burnham Medical Research Institute.
(TIF)
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